Literature DB >> 30767122

Xanthoceraside prevented synaptic loss and reversed learning-memory deficits in APP/PS1 transgenic mice.

Ge Jin1,2, Lin Zhu1,2, Peng Liu1, Qian Xu1, Yue Qi1, Xiaoyu Zhou1, Jikai Xu1, Xuefei Ji1, Tianyan Chi1, Libo Zou3.   

Abstract

Xanthoceraside, a novel triterpenoid saponin, has been found to attenuate learning and memory impairments in AD animal models. However, whether xanthoceraside has a positive effect on synaptic morphology remains unclear. Herein, we evaluated the effects of xanthoceraside on learning and memory impairments and the abnormalities of synaptic structure in APP/PS1 transgenic mice. The behavioral experiments demonstrated that xanthoceraside attenuated the imaginal memory and spatial learning impairments, and improved social interaction. Transmission electron microscopy and Golgi staining showed that xanthoceraside ameliorated synapse morphology abnormalities and dendritic spine density deficits, respectively. Western-blot analysis identified that xanthoceraside increased the expression of SYP and PSD95, activated BDNF/TrkB/MAPK/ERK and PI3K/Akt signaling pathways, meanwhile decreased the expression of RhoA, ROCK and Snk, increased the levels of SPAR, and activated the BDNF/TrkB/cofilin signaling pathway. Taken together, our study indicated that xanthoceraside improved cognitive function and protected both synaptic morphology and dendritic spine in APP/PS1 transgenic mice, which might be related in part to its activation in the BDNF/TrkB pathway.

Entities:  

Keywords:  BDNF; Learning and memory; Synaptic structure; TrkB; Xanthoceraside

Mesh:

Substances:

Year:  2019        PMID: 30767122     DOI: 10.1007/s12576-019-00664-x

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  61 in total

1.  Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.

Authors:  Shiyong Peng; Joanne Wuu; Elliott J Mufson; Margaret Fahnestock
Journal:  J Neurochem       Date:  2005-06       Impact factor: 5.372

2.  Functional convergence of Akt protein with VEGFR-1 in human endothelial progenitor cells exposed to sera from patient with type 2 diabetes mellitus.

Authors:  Mehdi Hassanpour; Aysa Rezabakhsh; Reza Rahbarghazi; Alireza Nourazarian; Mohammad Nouri; Çığır Biray Avci; Shahrooz Ghaderi; Neda Alidadyani; Bakiye Goker Bagca; Hesam Saghaei Bagheri
Journal:  Microvasc Res       Date:  2017-07-18       Impact factor: 3.514

3.  Lead, cadmium, arsenic, and mercury combined exposure disrupted synaptic homeostasis through activating the Snk-SPAR pathway.

Authors:  Fankun Zhou; Jie Xie; Shuyun Zhang; Guangming Yin; Yanyan Gao; Yuanyuan Zhang; Dandan Bo; Zongguang Li; Sisi Liu; Chang Feng; Guangqin Fan
Journal:  Ecotoxicol Environ Saf       Date:  2018-08-09       Impact factor: 6.291

4.  Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Hongxin Dong; Cynthia A Csernansky; Maureen V Martin; Amy Bertchume; Dana Vallera; John G Csernansky
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

5.  Activation of β2-adrenergic receptor promotes dendrite ramification and spine generation in APP/PS1 mice.

Authors:  Gao-Shang Chai; Yang-Yang Wang; Dan Zhu; Amina Yasheng; Peng Zhao
Journal:  Neurosci Lett       Date:  2016-11-09       Impact factor: 3.046

6.  Ciliary neurotrophic factor cell-based delivery prevents synaptic impairment and improves memory in mouse models of Alzheimer's disease.

Authors:  Pierre Garcia; Ihsen Youssef; Jo K Utvik; Sabrina Florent-Béchard; Vanassa Barthélémy; Catherine Malaplate-Armand; Badreddine Kriem; Christophe Stenger; Violette Koziel; Jean-Luc Olivier; Marie-Christine Escanye; Marine Hanse; Ahmad Allouche; Cédric Desbène; Frances T Yen; Rolf Bjerkvig; Thierry Oster; Simone P Niclou; Thierry Pillot
Journal:  J Neurosci       Date:  2010-06-02       Impact factor: 6.167

Review 7.  Stress and trauma: BDNF control of dendritic-spine formation and regression.

Authors:  M R Bennett; J Lagopoulos
Journal:  Prog Neurobiol       Date:  2013-11-06       Impact factor: 11.685

Review 8.  BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases.

Authors:  Bai Lu; Guhan Nagappan; Xiaoming Guan; Pradeep J Nathan; Paul Wren
Journal:  Nat Rev Neurosci       Date:  2013-05-15       Impact factor: 34.870

9.  PAK in Alzheimer disease, Huntington disease and X-linked mental retardation.

Authors:  Qiu-Lan Ma; Fusheng Yang; Sally A Frautschy; Greg M Cole
Journal:  Cell Logist       Date:  2012-04-01

10.  Degeneration and energy shortage in the suprachiasmatic nucleus underlies the circadian rhythm disturbance in ApoE-/- mice: implications for Alzheimer's disease.

Authors:  Lan Zhou; Qian Gao; Meng Nie; Jing-Li Gu; Wei Hao; Lin Wang; Ji-Min Cao
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

View more
  4 in total

1.  Loureirin C and Xanthoceraside Attenuate Depression-Like Behaviors and Expression of Interleukin-17 in the Prefrontal Cortex Induced by Chronic Unpredictable Mild Stress in Mice.

Authors:  Kazuo Kunisawa; Jiajing Shan; Qiaohui Lu; Yang Yang; Aika Kosuge; Hitomi Kurahashi; Kuniaki Saito; Libo Zou; Toshitaka Nabeshima; Akihiro Mouri
Journal:  Neurochem Res       Date:  2022-07-24       Impact factor: 4.414

2.  Learning and memory impairment induced by 1,4-butanediol is regulated by ERK1/2-CREB-BDNF signaling pathways in PC12 cells.

Authors:  Congying Chen; Lingling Bu; Huan Liu; Yifeng Rang; Huiying Huang; Xueman Xiao; Genghua Ou; Chunhong Liu
Journal:  Metab Brain Dis       Date:  2022-03-29       Impact factor: 3.655

3.  SIRT1 Is Involved in the Neuroprotection of Pterostilbene Against Amyloid β 25-35-Induced Cognitive Deficits in Mice.

Authors:  Lin Zhu; Fangjin Lu; Xiaoran Zhang; Siyuan Liu; Ping Mu
Journal:  Front Pharmacol       Date:  2022-04-14       Impact factor: 5.988

4.  GC/MS-Based Urine Metabolomics Study on the Ameliorative Effect of Xanthoceras sorbifolia Extract on Alzheimer's Disease in Mice.

Authors:  Rui Han; Min Wang; Li Wang; Yichen Zhang; Xin Li; Yijun Hou; Jing Yan; Xiaojing Pan
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-17       Impact factor: 2.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.